As drug development costs and significant time spent on clinical trials steadily increases and simultaneously, the number of global clinical trials is expected to increase over the next few years, which will bring a huge demand for new patients in almost every disease category. Inefficient patient recruitment can cause clinical trials to last 42% longer than expected in Phase I, 31% longer in Phase II and 30% in Phase III. These delays are extremely costly, estimated $600,000 per day in lost sales and as much as $8 million per day for potential blockbusters.

Followed by the great success of Clinical Trials Excellence forum 2007, the 2nd Annual Clinical Trials Excellence 2008 will further discuss the on-going pressing concerns faced in clinical trials operations, addressing the risks, timeline and budget constraint, whilst effectively tackling key challenges in overcoming trials agreement and site contract negotiation hurdles. This year, the operational element of trial site management, strategic partnership with CROs and SMOs, patient, talent & investigators management will be discussed in order to improve and optimise the overall drug development effectiveness and ROI. The 2nd Annual Clinical Trials Excellence Forum will also continue to cover how to implement and benefit from electronic data management & monitoring cost effectively.

At the 2nd Annual Clinical Trials Excellence 2008, best practice models will be shared by leading industrial practitioners across the region to promote practical discussions; especially on the know-how to manage needs, variability of different countries and institutions to enhance clinical operational excellence and vigilance. Delegates will have the opportunity to learn, network and benchmark against the global top pharmas and local industry leaders on the best practices in talent, site, budget and performance management in clinical trials.

Key benefits of attending this event:

This interactive forum featuring the expert insights on:

· Improving and optimising site management and overall productivity of clinical operations

· Working with limited budget to ensure on time study completion

· Escalating patient recruitment and improving patient retention to save cost and reduce lead-time

· Maximising trials results through overseas multinational/multi-centric trials

· Avoiding potential pitfalls of trials agreement

· Motivating and managing clinical project teams to improve timeline and progress

· Securing buy-ins and commitment from investigators to prevent costly delays

· Partnering with SMOs to increase the effectiveness of trial site management

· Gaining insights on future forwards of clinical trials in Asia and valuing its potential

· Attracting and retaining clinical talent pool to minimise turnover in clinical studies

· Exploring the feasibility of Phase I clinical trials in Asia

Some testimonials of past Marcus Evans' Life Sciences conferences and trainings:

"I enjoyed the conference and networking opportunity that Marcus Evans provided."

Regional Operations Director

US, Pfizer Inc (USA)

"Good speakers, well organized, provided me with lots of perspectives related to clinical trial sourcing."

Managing Director/ Regional Medical Director

Eisai (Singapore)

"Marcus Evans brought out a region-specific conference which highlighted the strengths of Asia as a region in global drug discovery paradigm."

Deputy Managing Director

Orchid Chemicals and Pharmaceuticals (India)

"It's an excellent activity pertinent to its topic."

CEO & CSO

AsiaGen Corporation (Taiwan)

"Well managed event."

Chief Operation Officer

Dr. Lal PathLabs (India)

"Well organised conference. Good insight."

Senior VP Medical Affairs & Clinical Research

IPCA Laboratories (India)

"Very effective organisation. Understands the needs of the market and provides events that addresses these needs."

Vice President

Accenture (India)

"Very well managed and organised meeting with ample time for networking."

Vice President

Elder Pharmaceuticals (India)

"Congratulation and hope to join your future events."

Head of Centre

Herbal Medicine Research Centre (Malaysia)

"Opening new horizon and keep you updated with well-selected topics and panel of

speakers."

Medical & Regulatory Director

Sanofi-Aventis Group (Indonesia)

"This event let me review the past experience for improvement."

Regulatory Affairs Director

International Nutrition Co, Dumex (China)

"Well organized and planned event. Good event for networking and exchange information."

Director-Clinical Operations

MakroCare (India)

"A good combination of project management and clinical research training."

Head of Clinical Research

Boehringer Ingelheim (China)

"I am impressed with your meetings. This is the second one I have attended."

Senior Consultant

Dr. B L Kapur Memorial Hospital (India)

"This training is what I need, what I'm looking for. The trainer is an excellent trainer and a great expert in clinical project management. Abundant examples and workshops make the training easy to understand and remember."

Medical Quality and Planning Manager

Eli Lilly (China)

For event brochure, please contact: